Dr Jean Jacques Fournié is completed his PhD (Biochemistry and Immunology) from Toulouse University and Post-doctoral studies at the Clinical Immunology Research Center of the University of Sydney, Australia. He was a founder of Innate Pharma, a company developing NK cell therapies for cancer. Dr. Fournié is also the Founding Director of Cancer Research Center of Toulouse, an international cancer research laboratory from INSERM, University of Toulouse 3 and CNRS, and leads the research team ‘Innovating Therapeutics Strategies in Lymphomas’ of Laboratoire d’Excellence Toulouse Cancer at Institut Universitaire du Cancer of Toulouse-Oncopole, France.